Fulcrum Therapeutics Inc

NASDAQ:FULC   4:00:00 PM EDT
6.85
+0.30 (+4.58%)
6:29:54 PM EDT: $6.51 -0.34 (-4.96%)
Other Pre-Announcement

Fulcrum Therapeutics Reports Q3 Loss Of $0.51 Per Share

Published: 11/08/2022 13:07 GMT
Fulcrum Therapeutics Inc (FULC) - Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results.
Updated Cash Runway Guidance Into Late 2024.
Fulcrum Therapeutics - Collaboration Revenue Was $1.2 Million for Q3 of 2022, As Compared to $4.9 Million for Q3 of 2021.
Qtrly Loss per Share $0.51.
Q3 Earnings per Share View $-0.61, Revenue View $2.5 Million -- Refinitiv Ibes Data (analyst estimates).